Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Molecular Analysis for Precision Oncology Congress 2023, 4–6 October 2023 Paris, France

26 Sep 2023

The Molecular Analysis for Precision Oncology Congress 2023 (MAP) is the appointment where experts present the latest developments and discuss the present and future of the rapidly evolving field of precision oncology, whose aim is to identify genomic alterations to provide the best possible personalised treatment to patients with cancer. The congress will be held in Paris, France, between 4-6 October.

New this year

  • A special day (6 October, 9:30-15:00 CEST) dedicated to applying precision medicine research to patient care. The so-called RoadMAP to the Clinic 2023 will aim to give visibility to the developments towards molecularly informed, resource-rational and timely advancement of the therapeutic options for patients with cancer. The sessions will deal with the current landscape of research and development and approval of precision therapeutics, with spotlight on the challenge of optimisation, new trial designs and new paths to drug registration; current roadblocks to and future of pan-cancer approvals based on histology agnostic biomarkers.

Programme highlights

  • Multimodal single cell characterization or application of whole-genome sequencing? How to derive a more complete understanding of cancer spatial resolution
    • Related content: Session on 4 October, 9:30-11:00 CEST
  • Evolution-based methods, mathematical modelling, and the tumour microenvironment: improve cancer treatment by understanding the process of clonal evolution and the drivers of cancers
    • Related content: Session on 4 October, 11:30-13:00 CEST and 14:40-16:10 CEST
  • New insights into resistance mechanisms in cancer to advance personalized therapies and improve patient outcomes
    • Related content: Abstract 5O

Keynote lectures

The results of 169 studies from various parts of the world will be presented and published online as a supplement to ESMO Open. The abstract titles can be viewed through the online programme.

Press registration

The MAP organisers welcome press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities. To apply for press accreditation, please fill out the form available here. Requests for press accreditation should be sent by Tuesday, 3 October. Please be kindly informed that onsite press accreditations will not be available.

Further information

MAP Press Office

MAP is a joint initiative of Cancer Research UK (CRUK), Unicancer and the European Society for Medical Oncology (ESMO).

Notes to Editors

Please make sure to use the official name of the meeting in your reports: MAP 2023 and the official congress hashtag #MAP2023. Follow it to stay up to date and use it to take part in the conversation on X (Twitter), LinkedIn, Instagram, Facebook

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.